KAT7 promotes radioresistance through upregulating PI3K/AKT signaling in breast cancer

Abstract Chromatin-modifying enzymes are commonly altered in cancers, but the molecular mechanism by which they regulate cancers remains poorly understood. Herein, we demonstrated that Lysine acetyltransferase 7 (KAT7) was upregulated in breast cancer. KAT7 expression negatively correlated with the survival of breast cancer patients, and KAT7 silencing suppressed breast cancer radioresistance in vitro. Mechanistically, KAT7 activated Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) transcription, leading to enhanced PI3K/AKT signaling and radioresistance. Overexpression of AKT or PIK3CA restored radioresistance suppression induced by KAT7 inhibition. Moreover, overexpression of KAT7, but not KAT7 acetyltransferase activity-deficient mutants promoted AKT phosphorylation at the Ser473 site, PIK3CA expression and radioresistance suppression due to KAT7 inhibition. In conclusion, KAT7 has huge prospects for clinical application as a new target for predicting radioresistance in breast cancer patients.

[1]  G. Vassiliou,et al.  KAT7 is a genetic vulnerability of acute myeloid leukemias driven by MLL rearrangements , 2020, Leukemia.

[2]  F. He,et al.  CircMRPS35 suppresses gastric cancer progression via recruiting KAT7 to govern histone modification , 2020, Molecular Cancer.

[3]  R. Xu,et al.  Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? , 2019, Cancer communications.

[4]  R. S. Conlan,et al.  HBO1 directs histone H4 specific acetylation, potentiating mechano-transduction pathways and membrane elasticity in ovarian cancer cells. , 2019, Nanomedicine : nanotechnology, biology, and medicine.

[5]  R. Marmorstein,et al.  The scaffolding protein JADE1 physically links the acetyltransferase subunit HBO1 with its histone H3–H4 substrate , 2018, The Journal of Biological Chemistry.

[6]  Lijie Zhou,et al.  HBO1 promotes cell proliferation in bladder cancer via activation of Wnt/β‐catenin signaling , 2018, Molecular carcinogenesis.

[7]  J. Strasser,et al.  Updates in the Treatment of Breast Cancer with Radiotherapy. , 2017, Surgical oncology clinics of North America.

[8]  A. Voss,et al.  Essential role for the histone acetyltransferase KAT7 in T cell development, fitness, and survival , 2017, Journal of leukocyte biology.

[9]  T. Nagase,et al.  KAT7/HBO1/MYST2 Regulates CENP-A Chromatin Assembly by Antagonizing Suv39h1-Mediated Centromere Inactivation , 2016, Developmental cell.

[10]  Anne-Claude Gingras,et al.  BRPF3‐HBO1 regulates replication origin activation and histone H3K14 acetylation , 2016, The EMBO journal.

[11]  Xiang-Jiao Yang,et al.  The Chromatin Regulator BRPF3 Preferentially Activates the HBO1 Acetyltransferase but Is Dispensable for Mouse Development and Survival* , 2015, The Journal of Biological Chemistry.

[12]  B. Kamińska,et al.  Deregulation of histone-modifying enzymes and chromatin structure modifiers contributes to glioma development. , 2015, Future oncology.

[13]  Wanqing Chen,et al.  Cancer statistics: updated cancer burden in China. , 2015, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[14]  D. Low,et al.  Radioresistance of the breast tumor is highly correlated to its level of cancer stem cell and its clinical implication for breast irradiation. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  M. Luftig.  Heavy LIFting: tumor promotion and radioresistance in NPC. , 2013, The Journal of clinical investigation.

[16]  H. Okinaga,et al.  Histone acetyltransferase Hbo1 destabilizes estrogen receptor α by ubiquitination and modulates proliferation of breast cancers , 2013, Cancer science.

[17]  M. Holliday,et al.  Exchange of associated factors directs a switch in HBO1 acetyltransferase histone tail specificity , 2013, Genes & development.

[18]  K. Hunt,et al.  Hbo1 is a cyclin E/CDK2 substrate that enriches breast cancer stem-like cells. , 2013, Cancer research.

[19]  Jian Luo,et al.  Small-Molecule Inhibitors of Acetyltransferase p300 Identified by High-Throughput Screening Are Potent Anticancer Agents , 2013, Molecular Cancer Therapeutics.

[20]  R. Schneider,et al.  Targeting histone modifications--epigenetics in cancer. , 2013, Current opinion in cell biology.

[21]  David T. W. Jones,et al.  Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma , 2012, Nature.

[22]  Y. Doyon,et al.  Conserved Molecular Interactions within the HBO1 Acetyltransferase Complexes Regulate Cell Proliferation , 2011, Molecular and Cellular Biology.

[23]  A. Iwama,et al.  The Hbo1-Brd1/Brpf2 complex is responsible for global acetylation of H3K14 and required for fetal liver erythropoiesis. , 2011, Blood.

[24]  A. Voss,et al.  HBO1 Is Required for H3K14 Acetylation and Normal Transcriptional Activity during Embryonic Development , 2010, Molecular and Cellular Biology.

[25]  Lei Zhou,et al.  Estrogen receptor α (ERα) mediates 17β-estradiol (E2)-activated expression of HBO1 , 2010, Journal of experimental & clinical cancer research : CR.

[26]  Daniele Soria,et al.  Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. , 2009, Cancer research.

[27]  Thomas D. Wu,et al.  Genetic Alterations and Oncogenic Pathways Associated with Breast Cancer Subtypes , 2009, Molecular Cancer Research.

[28]  T. Hung,et al.  HBO1 HAT complexes target chromatin throughout gene coding regions via multiple PHD finger interactions with histone H3 tail. , 2009, Molecular cell.

[29]  K. Struhl,et al.  HBO1 histone acetylase is a coactivator of the replication licensing factor Cdt1. , 2008, Genes & development.

[30]  Yoshikazu Johmura,et al.  FAD24 Acts in Concert with Histone Acetyltransferase HBO1 to Promote Adipogenesis by Controlling DNA Replication* , 2008, Journal of Biological Chemistry.

[31]  H. Takisawa,et al.  Regulation of Replication Licensing by Acetyltransferase Hbo1 , 2006, Molecular and Cellular Biology.

[32]  Song Tan,et al.  ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation. , 2006, Molecular cell.

[33]  Carlo Rago,et al.  Mutant PIK3CA promotes cell growth and invasion of human cancer cells. , 2005, Cancer cell.

[34]  B. Stillman,et al.  Histone Acetyltransferase HBO1 Interacts with the ORC1 Subunit of the Human Initiator Protein* , 1999, The Journal of Biological Chemistry.

[35]  Peijun Wang,et al.  Molecular Carcinogenesis , 2020 .

[36]  Gordon B Mills,et al.  Targeting the Phosphatidylinositol 3-Kinase / Akt Pathway for Enhancing Breast Cancer Cells to Radiotherapy 1 , 2003 .